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Atopic dermatitis (AD) is a common chronic in-
flammatory skin disease characterized by itching
and inflamed skin, showing from infancy and
early childhood.1 It affects up to 20% of children
with increasing prevalence in highly industrial-
ized countries.1 Until recently, most pathophy-
siological concepts of AD have been attributed 
to immune system abnormalities, including Th1/
Th2 imbalance and IgE-mediated sensitization.1
However, there is growing evidence to show that
heritable skin barrier defects caused by mutations
in the human profilaggrin gene (FLG) play an
important role in AD.2
Filaggrin
Filaggrin, processed from profilaggrin, plays an
essential role in epidermal barrier formation in
the stratum corneum which forms the outermost
layer of the skin, keeping skin hydrated and act-
ing as a barrier against environmental assaults.
Filaggrin aggregates keratin filaments as the ker-
atinocytes collapse in the stratum corneum, and
is subsequently disassembled into amino acids
which act in retaining epidermal moisture. FLG
resides on chromosome 1q21 and consists of three
exons.3 Exon 3 is extremely large (>12 kb) and
encodes most of the profilaggrin polypeptides with
almost completely homologous 10, 11 or 12 re-
peats.4 The huge size as well as high number of
sequence repetitions prevent sequencing of the
entire gene.
Filaggrin Mutations Underlie Ichthyosis
Vulgaris
Recently, Smith et al first identified FLG muta-
tions R501X and 2282del4 as the cause of ichth-
yosis vulgaris.5 Ichthyosis vulgaris is a common
genetic skin disease characterized by dry and scaly
skin, especially on the flexor limbs, and palmo-
plantar hyperlinearity. After the establishment 
of sequencing of the entire FLG gene,6 the total
number of FLG mutations reported in ichthyosis
vulgaris is 22 to date.7–10 In addition, these mu-
tations are semidominant with incomplete pene-
trance.10 Those who are heterozygous show a mild
phenotype. Among these studies, Nomura et al
revealed four FLG mutations among Japanese
ichthyosis vulgaris patients which are unique from
those found in populations of European origin.7,8
Chen et al discovered five unique mutations and
one recurrent mutation in Singaporean Chinese
ichthyosis vulgaris patients.9 These results suggest
that FLG mutations may have regional or ethnic
differences.
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NEWS AND PERSPECTIVES
Filaggrin Mutations as Major
Predisposing Factors for AD
The genome-wide linkage studies for AD revealed
significant linkage to the same gene region of fi-
laggrin.11 In addition, ichthyosis vulgaris is known
to be associated with a high incidence of AD and
share some clinical features, such as dry scaly skin
and keratosis pilaris. Therefore, an association
between FLG-null mutations and AD was subse-
quently established.12 Palmer et al discovered two
FLG-null mutations (R510X and 2282del4) that
were strong predisposing factors for AD (odds
ratio=13.4).12 The further study demonstrated that
these FLG mutations predispose for early-onset
AD, which persists into adulthood.13 Nomura 
et al also showed that there was statistically sig-
nificant association between four Japanese FLG
mutations and AD (odds ratio = 7.57).7
Filaggrin Mutations Also Predispose to
Asthma
Previous studies showed that 70% of patients with
severe AD developed asthma compared with
30% of patients with mild AD and approximately
8% of the general population.14 In addition, AD
is typically the first clinical manifestation of al-
lergic diseases, followed by the development of
asthma and allergic rhinitis.14 The process of atopic
diseases is the so-called “atopic march”, which
suggests a common etiology among these various
atopic diseases.
Recent studies hypothesized that the damage
to the skin barrier caused by FLG mutations al-
lows allergens to penetrate into the epidermis and
subepithelial tissues and to interact with antigen
presenting cells, known as Langerhans cells and
dermal dendritic cells, which might further initi-
ate Th2 immune response and lead to the devel-
opment of systemic allergies, including allergic
rhinitis and atopic asthma.15 Palmer et al found
that FLG mutations are significantly associated
with the subgroup of asthmatics with AD.12 In
addition, FLG mutations were notably associated
with greater asthma severity.16 Thus, FLG muta-
tions are responsible for mild to severe ichthyosis
vulgaris and also for allergic diseases, including
AD as well as asthma.
Prospective Taiwanese Filaggrin
Mutations
One recent cross-sectional study in Taiwan showed
that the prevalence of AD was 1.7% among chil-
dren in the southern part of Taiwan.17 The preva-
lence is relatively low and has changed little over
the past decade (2% in 1994) compared with
Western countries and other Asian countries.18
Data on Taiwanese FLG mutations are limited.
The only report showed that both the European-
specific mutations R501X and 2282del4 were ab-
sent in Taiwanese psoriasis patients.19 Data from
common single-nucleotide polymorphism analysis
and human leukocyte antigen haplotype analysis
suggest that Taiwanese might share similar FLG
mutations with Singaporean Chinese.9,20,21 We
believe that the analysis of FLG mutations in the
Taiwanese population is likely to reveal the overall
contribution of FLG mutations to the pathogenesis
of atopic diseases.
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